The company’s mission lies in providing professional assistance to pharmaceutical and biotechnical companies in carrying out the CR of new medicines, with all the rules and ethical principles accepted in this field being observed.
The main standard of planning, organizing and carrying out clinical tests of medicines with humans involved, as well as of arranging and presenting their results, is the proper clinical practice manual «ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice» (E6(R1.) 10 June 1996), which was developed during the international Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use — ICH.
The company is guided in its work by the professional approach to solving the problems posed. All the projects are done in accordance with the demands of regulatory organs, the RF legislation, standard operation procedure and the agreed liabilities.